Jaguar Health (JAGX) Shares Down 11.8%

Jaguar Health Inc (NASDAQ:JAGX) shares were down 11.8% during trading on Monday . The company traded as low as $0.15 and last traded at $0.15. Approximately 12,158,500 shares traded hands during trading, an increase of 115% from the average daily volume of 5,657,977 shares. The stock had previously closed at $0.17.

The firm has a market capitalization of $17.61 and a P/E ratio of -0.24. The company has a quick ratio of 0.15, a current ratio of 0.26 and a debt-to-equity ratio of 0.35.

Jaguar Health (NASDAQ:JAGX) last issued its quarterly earnings data on Monday, November 20th. The biotechnology company reported $0.13 EPS for the quarter. Jaguar Health had a negative return on equity of 17.50% and a negative net margin of 190.94%.

COPYRIGHT VIOLATION WARNING: “Jaguar Health (JAGX) Shares Down 11.8%” was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.com-unik.info/2018/01/22/jaguar-health-jagx-shares-down-11-8.html.

About Jaguar Health

Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit